RadiotherapyAdenocarcinomaRaloxifeneWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.AdvocacyBreastCancerAngiogenesisTumorGradeMorpheaCheckpointInhibitorMegestrolAcetatePI3KinaseInhibitorsKappaEpsilonSelf-examinationCytotoxicTamoxifenCytostaticMetastasisACChemotherapyTyrosine-KinaseInhibitorBI-RADSMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltPhysicalactivity mayreduce therisk of breastcancersDimplingNeoadjuvantTherapyApoptosisOvarianSuppressionAnastrozoleChemopreventionER+Women ages40+ shouldhave a clinicalbreast examat least yearlymTORInhibitorsAlopeciaHormoneReceptorStatusCMFChemotherapyDoxorubicinPrecisionMedicineRelapseMultimodalityTherapyTriple +/-BreastCancerAntiemeticIn-situCarcinomaPathologicResponseGeneticPredispositionFamilyHistoryAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerER-SERMBilateralProphylacticMastectomyLumpectomyGenomicTestingBiopsyImmunotherapyPhyllodesTumorCachexiaDefinitiveSurgeryKi-67RatePaclitaxelAyurvedaHormoneReplacementTherapyBOCACAMLymphNodeStatusGermlineMutationGailModelMethotrexateLapatinibECOGScoreEstradiolOligometastases5-FluorouracilMRIEstrogenBrachytherapyMultifocalTumorsAntibodyTherapyDocetaxelChemotherapyPARPInhibitorsFlowCytometryLCISAbsoluteRiskCapecitabineCystCalcificationsBreastTomosynthesisEGFRCyclophosphamidePalbociclibAxillarySamplingHerceptinCo-survivorMastodyniaDoseDenseTherapyProgestinFibroadenomaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearCDK4/6InhibitorsPalpationFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.GuaranteedRenewableInsuranceGeneMutationLumpMastectomyDown-StagingBevacizumabPagetDiseaseBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55AromataseInhibitorsIntraductalPapillomaAdjuvantTherapy1 in 8womenFISHGeneticCounselingRADLymphoscintigraphyHER-2BRCAGeneAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenStagingRadiotherapyAdenocarcinomaRaloxifeneWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.AdvocacyBreastCancerAngiogenesisTumorGradeMorpheaCheckpointInhibitorMegestrolAcetatePI3KinaseInhibitorsKappaEpsilonSelf-examinationCytotoxicTamoxifenCytostaticMetastasisACChemotherapyTyrosine-KinaseInhibitorBI-RADSMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltPhysicalactivity mayreduce therisk of breastcancersDimplingNeoadjuvantTherapyApoptosisOvarianSuppressionAnastrozoleChemopreventionER+Women ages40+ shouldhave a clinicalbreast examat least yearlymTORInhibitorsAlopeciaHormoneReceptorStatusCMFChemotherapyDoxorubicinPrecisionMedicineRelapseMultimodalityTherapyTriple +/-BreastCancerAntiemeticIn-situCarcinomaPathologicResponseGeneticPredispositionFamilyHistoryAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerER-SERMBilateralProphylacticMastectomyLumpectomyGenomicTestingBiopsyImmunotherapyPhyllodesTumorCachexiaDefinitiveSurgeryKi-67RatePaclitaxelAyurvedaHormoneReplacementTherapyBOCACAMLymphNodeStatusGermlineMutationGailModelMethotrexateLapatinibECOGScoreEstradiolOligometastases5-FluorouracilMRIEstrogenBrachytherapyMultifocalTumorsAntibodyTherapyDocetaxelChemotherapyPARPInhibitorsFlowCytometryLCISAbsoluteRiskCapecitabineCystCalcificationsBreastTomosynthesisEGFRCyclophosphamidePalbociclibAxillarySamplingHerceptinCo-survivorMastodyniaDoseDenseTherapyProgestinFibroadenomaEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearCDK4/6InhibitorsPalpationFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.GuaranteedRenewableInsuranceGeneMutationLumpMastectomyDown-StagingBevacizumabPagetDiseaseBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55AromataseInhibitorsIntraductalPapillomaAdjuvantTherapy1 in 8womenFISHGeneticCounselingRADLymphoscintigraphyHER-2BRCAGeneAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenStaging

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
  1. Radiotherapy
  2. Adenocarcinoma
  3. Raloxifene
  4. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  5. Advocacy
  6. Breast Cancer
  7. Angiogenesis
  8. Tumor Grade
  9. Morphea
  10. Checkpoint Inhibitor
  11. Megestrol Acetate
  12. PI3 Kinase Inhibitors
  13. Kappa Epsilon
  14. Self-examination
  15. Cytotoxic
  16. Tamoxifen
  17. Cytostatic
  18. Metastasis
  19. AC Chemotherapy
  20. Tyrosine-Kinase Inhibitor
  21. BI-RADS
  22. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  23. Physical activity may reduce the risk of breast cancers
  24. Dimpling
  25. Neoadjuvant Therapy
  26. Apoptosis
  27. Ovarian Suppression
  28. Anastrozole
  29. Chemoprevention
  30. ER+
  31. Women ages 40+ should have a clinical breast exam at least yearly
  32. mTOR Inhibitors
  33. Alopecia
  34. Hormone Receptor Status
  35. CMF Chemotherapy
  36. Doxorubicin
  37. Precision Medicine
  38. Relapse
  39. Multimodality Therapy
  40. Triple +/- Breast Cancer
  41. Antiemetic
  42. In-situ Carcinoma
  43. Pathologic Response
  44. Genetic Predisposition
  45. Family History
  46. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  47. ER-
  48. SERM
  49. Bilateral Prophylactic Mastectomy
  50. Lumpectomy
  51. Genomic Testing
  52. Biopsy
  53. Immunotherapy
  54. Phyllodes Tumor
  55. Cachexia
  56. Definitive Surgery
  57. Ki-67 Rate
  58. Paclitaxel
  59. Ayurveda
  60. Hormone Replacement Therapy
  61. BOCA
  62. CAM
  63. Lymph Node Status
  64. Germline Mutation
  65. Gail Model
  66. Methotrexate
  67. Lapatinib
  68. ECOG Score
  69. Estradiol
  70. Oligometastases
  71. 5-Fluorouracil
  72. MRI
  73. Estrogen
  74. Brachytherapy
  75. Multifocal Tumors
  76. Antibody Therapy
  77. Docetaxel
  78. Chemotherapy
  79. PARP Inhibitors
  80. Flow Cytometry
  81. LCIS
  82. Absolute Risk
  83. Capecitabine
  84. Cyst
  85. Calcifications
  86. Breast Tomosynthesis
  87. EGFR
  88. Cyclophosphamide
  89. Palbociclib
  90. Axillary Sampling
  91. Herceptin
  92. Co-survivor
  93. Mastodynia
  94. Dose Dense Therapy
  95. Progestin
  96. Fibroadenoma
  97. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  98. CDK4/6 Inhibitors
  99. Palpation
  100. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  101. Guaranteed Renewable Insurance
  102. Gene Mutation
  103. Lump
  104. Mastectomy
  105. Down-Staging
  106. Bevacizumab
  107. Paget Disease
  108. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  109. Aromatase Inhibitors
  110. Intraductal Papilloma
  111. Adjuvant Therapy
  112. 1 in 8 women
  113. FISH
  114. Genetic Counseling
  115. RAD
  116. Lymphoscintigraphy
  117. HER-2
  118. BRCA Gene
  119. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  120. Staging